143 (PB131): Preliminary Safety and Pharmacokinetics of the MET-TKI DO-2 in Patients with Advanced Solid Tumors Harboring MET Aberrations: A Phase I Study von Perera, T., Sikkema, B., Dekeyser, B., de Bruijn, P., Zammit, F., Galot, R., Machielsjean-pascal.machiels@saintluc.uclouvain.be, J.P., Delafontaine, B., Rottey, S., Swalduz, A., Ghiringhelli, F., Piet, B., van Herpen, C., Cortot, A., Wastelin, F., Verweij, J., Mathijssen, R., Robbrecht, D., Prenen, H.

Volltext